Application 206318
- Type
- ANDA
- Sponsor
- ZYDUS NOVELTECH INC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | RIVASTIGMINE | RIVASTIGMINE | FILM, EXTENDED RELEASE;TRANSDERMAL | 4.6MG/24HR | No | No |
| 002 | RIVASTIGMINE | RIVASTIGMINE | FILM, EXTENDED RELEASE;TRANSDERMAL | 9.5MG/24HR | No | No |
| 003 | RIVASTIGMINE | RIVASTIGMINE | FILM, EXTENDED RELEASE;TRANSDERMAL | 13.3MG/24HR | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 16714-115 | Rivastigmine | Rivastigmine | Northstar Rx LLC. | ANDA | Current |
| 16714-115 | Rivastigmine | Rivastigmine | Northstar Rx LLC. | ANDA | Current |
| 16714-115 | Rivastigmine | Rivastigmine | Northstar Rx LLC. | ANDA | Current |
| 16714-116 | Rivastigmine | Rivastigmine | Northstar Rx LLC. | ANDA | Current |
| 16714-116 | Rivastigmine | Rivastigmine | Northstar Rx LLC. | ANDA | Current |
| 16714-116 | Rivastigmine | Rivastigmine | Northstar Rx LLC. | ANDA | Current |
| 16714-117 | Rivastigmine | Rivastigmine | Northstar Rx LLC. | ANDA | Current |
| 16714-117 | Rivastigmine | Rivastigmine | Northstar Rx LLC. | ANDA | Current |
| 16714-117 | Rivastigmine | Rivastigmine | Northstar Rx LLC. | ANDA | Current |
| 51956-0001 | Rivastigmine | Rivastigmine | Zydus Lifesciences Limited | ANDA | Current |
| 51956-0001 | Rivastigmine | Rivastigmine | Cadila Healthcare Limited | ANDA | Current |
| 51956-0001 | Rivastigmine | Rivastigmine | Zydus Technologies Limited | ANDA | Current |
| 51956-0002 | Rivastigmine | Rivastigmine | Cadila Healthcare Limited | ANDA | Current |
| 51956-0002 | Rivastigmine | Rivastigmine | Zydus Technologies Limited | ANDA | Current |
| 51956-0002 | Rivastigmine | Rivastigmine | Zydus Lifesciences Limited | ANDA | Current |
| 51956-0003 | Rivastigmine | Rivastigmine | Zydus Lifesciences Limited | ANDA | Current |
| 51956-0003 | Rivastigmine | Rivastigmine | Cadila Healthcare Limited | ANDA | Current |
| 51956-0003 | Rivastigmine | Rivastigmine | Zydus Technologies Limited | ANDA | Current |
| 70710-1196 | Rivastigmine | Rivastigmine | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 70710-1196 | Rivastigmine | Rivastigmine | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 70710-1196 | Rivastigmine | Rivastigmine | Zydus Pharmaceuticals USA Inc. | ANDA | Current |
| 70710-1197 | Rivastigmine | Rivastigmine | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 70710-1197 | Rivastigmine | Rivastigmine | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 70710-1197 | Rivastigmine | Rivastigmine | Zydus Pharmaceuticals USA Inc. | ANDA | Current |
| 70710-1198 | Rivastigmine | Rivastigmine | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 70710-1198 | Rivastigmine | Rivastigmine | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 70710-1198 | Rivastigmine | Rivastigmine | Zydus Pharmaceuticals USA Inc. | ANDA | Current |